<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SLS Invest</title>
	<atom:link href="http://slsinvest.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://slsinvest.com</link>
	<description>Life Science Investments</description>
	<lastBuildDate>Mon, 20 Feb 2012 11:27:22 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>17/02/12</title>
		<link>http://slsinvest.com/press-release/170212-6/</link>
		<comments>http://slsinvest.com/press-release/170212-6/#comments</comments>
		<pubDate>Mon, 20 Feb 2012 11:27:22 +0000</pubDate>
		<dc:creator>asa.norman</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://slsinvest.com/?p=1226</guid>
		<description><![CDATA[Doxa lanserar ny produkt: Ceramir Crown &#38; Bridge SingleCap]]></description>
			<content:encoded><![CDATA[<p>Doxa lanserar ny produkt: Ceramir Crown &amp; Bridge SingleCap</p>
]]></content:encoded>
			<wfw:commentRss>http://slsinvest.com/press-release/170212-6/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>17/12/11</title>
		<link>http://slsinvest.com/press-release/171211/</link>
		<comments>http://slsinvest.com/press-release/171211/#comments</comments>
		<pubDate>Wed, 07 Dec 2011 11:22:56 +0000</pubDate>
		<dc:creator>asa.norman</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://slsinvest.com/?p=1223</guid>
		<description><![CDATA[Gyros expands commercial reach in Asia.]]></description>
			<content:encoded><![CDATA[<p>Gyros expands commercial reach in Asia.</p>
]]></content:encoded>
			<wfw:commentRss>http://slsinvest.com/press-release/171211/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>13/10/11</title>
		<link>http://slsinvest.com/press-release/131011-3/</link>
		<comments>http://slsinvest.com/press-release/131011-3/#comments</comments>
		<pubDate>Thu, 13 Oct 2011 14:30:09 +0000</pubDate>
		<dc:creator>asa.norman</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://slsinvest.com/?p=1091</guid>
		<description><![CDATA[New Study Shows PNA FISH® Test Reporting Dramtically Decreased Mortality and Hospital Costs for Patients with Bloodstream Infections]]></description>
			<content:encoded><![CDATA[<p align="left">New Study Shows PNA FISH® Test Reporting Dramtically Decreased Mortality and Hospital Costs for Patients with Bloodstream Infections</p>
]]></content:encoded>
			<wfw:commentRss>http://slsinvest.com/press-release/131011-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>11/10/11</title>
		<link>http://slsinvest.com/press-release/111011/</link>
		<comments>http://slsinvest.com/press-release/111011/#comments</comments>
		<pubDate>Tue, 11 Oct 2011 08:58:57 +0000</pubDate>
		<dc:creator>asa.norman</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://slsinvest.com/?p=1079</guid>
		<description><![CDATA[Gyros introduces new application to monitor anti-drug antibodies during development of biotherapeutics]]></description>
			<content:encoded><![CDATA[<p>Gyros introduces new application to monitor anti-drug antibodies during development of biotherapeutics</p>
]]></content:encoded>
			<wfw:commentRss>http://slsinvest.com/press-release/111011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>07/10/11</title>
		<link>http://slsinvest.com/press-release/071011/</link>
		<comments>http://slsinvest.com/press-release/071011/#comments</comments>
		<pubDate>Fri, 07 Oct 2011 07:38:54 +0000</pubDate>
		<dc:creator>asa.norman</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://slsinvest.com/?p=1063</guid>
		<description><![CDATA[Mårten Winge new CEO at Doxa]]></description>
			<content:encoded><![CDATA[<p>Mårten Winge new CEO at Doxa</p>
]]></content:encoded>
			<wfw:commentRss>http://slsinvest.com/press-release/071011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>26/09/11</title>
		<link>http://slsinvest.com/press-release/260911/</link>
		<comments>http://slsinvest.com/press-release/260911/#comments</comments>
		<pubDate>Mon, 26 Sep 2011 13:34:47 +0000</pubDate>
		<dc:creator>martin</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://slsinvest.com/?p=1055</guid>
		<description><![CDATA[Action Pharma’s phase IIb clinical trial with AP214 to prevent kidney injury associated with major cardiac surgery demonstrates positive top-line results]]></description>
			<content:encoded><![CDATA[<p>Action Pharma’s phase IIb clinical trial with AP214 to prevent kidney injury associated with major cardiac surgery demonstrates positive top-line results</p>
]]></content:encoded>
			<wfw:commentRss>http://slsinvest.com/press-release/260911/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>20/09/2011</title>
		<link>http://slsinvest.com/press-release/20092011/</link>
		<comments>http://slsinvest.com/press-release/20092011/#comments</comments>
		<pubDate>Mon, 26 Sep 2011 13:29:32 +0000</pubDate>
		<dc:creator>martin</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://slsinvest.com/?p=1051</guid>
		<description><![CDATA[Nuevolution Announces Collaboration in Drug Discovery with Boehringer Ingelheim Partnership to use Nuevolution&#8217;s Chemetics® Technology for Lead Discovery]]></description>
			<content:encoded><![CDATA[<p>Nuevolution Announces Collaboration in Drug Discovery with Boehringer Ingelheim<br />
Partnership to use Nuevolution&#8217;s Chemetics® Technology for Lead Discovery</p>
]]></content:encoded>
			<wfw:commentRss>http://slsinvest.com/press-release/20092011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>05/09/2011</title>
		<link>http://slsinvest.com/press-release/05092011/</link>
		<comments>http://slsinvest.com/press-release/05092011/#comments</comments>
		<pubDate>Mon, 05 Sep 2011 06:48:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://slsinvest.com/?p=1020</guid>
		<description><![CDATA[Ingelise Saunders appointed CEO of SLS Invest.]]></description>
			<content:encoded><![CDATA[<p>Ingelise Saunders appointed CEO of SLS Invest.</p>
]]></content:encoded>
			<wfw:commentRss>http://slsinvest.com/press-release/05092011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>26/08/2011</title>
		<link>http://slsinvest.com/press-release/26082011/</link>
		<comments>http://slsinvest.com/press-release/26082011/#comments</comments>
		<pubDate>Fri, 26 Aug 2011 13:37:47 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://slsweb.cag.se/?p=616</guid>
		<description><![CDATA[Gyros and GE Healthcare Life Sciences expand Asian distribution relationship to China, Taiwan and Hong Kong]]></description>
			<content:encoded><![CDATA[<p>Gyros and GE Healthcare Life Sciences expand Asian distribution relationship to China, Taiwan and Hong Kong</p>
]]></content:encoded>
			<wfw:commentRss>http://slsinvest.com/press-release/26082011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ingelise Saunders, CEO</title>
		<link>http://slsinvest.com/first-page-info/ingelise-saunders-ceo/</link>
		<comments>http://slsinvest.com/first-page-info/ingelise-saunders-ceo/#comments</comments>
		<pubDate>Fri, 26 Aug 2011 13:21:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[First Page Info]]></category>

		<guid isPermaLink="false">http://www.danielcarlson.se/testsite/?p=512</guid>
		<description><![CDATA[&#8220;I am proud to present our portfolio of life science companies supported by a newly implemented robust owner&#8217;s strategy.&#8221;]]></description>
			<content:encoded><![CDATA[<p><a href="http://danielcarlson.se/testsite/portfolio">&#8220;I am proud to present our portfolio of life science companies supported by a newly implemented robust owner&#8217;s strategy.&#8221;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://slsinvest.com/first-page-info/ingelise-saunders-ceo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

